133 related articles for article (PubMed ID: 32453493)
1. Enantioselective Synthesis of Planar Chiral Ferrocifens that Show Chiral Discrimination in Antiproliferative Activity on Breast Cancer Cells.
Cunningham L; Wang Y; Nottingham C; Pagsulingan J; Jaouen G; McGlinchey MJ; Guiry PJ
Chembiochem; 2020 Oct; 21(20):2974-2981. PubMed ID: 32453493
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
3. Enantioselective synthesis of ferrocenyl nucleoside analogues with apoptosis-inducing activity.
James P; Neudörfl J; Eissmann M; Jesse P; Prokop A; Schmalz HG
Org Lett; 2006 Jun; 8(13):2763-6. PubMed ID: 16774251
[TBL] [Abstract][Full Text] [Related]
4. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
Buriez O; Heldt JM; Labbé E; Vessières A; Jaouen G; Amatore C
Chemistry; 2008; 14(27):8195-203. PubMed ID: 18668496
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of ferrocene derivatives with planar chirality via palladium-catalyzed enantioselective C-H bond activation.
Pi C; Cui X; Liu X; Guo M; Zhang H; Wu Y
Org Lett; 2014 Oct; 16(19):5164-7. PubMed ID: 25247387
[TBL] [Abstract][Full Text] [Related]
6. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
[TBL] [Abstract][Full Text] [Related]
7. Enantioselective synthesis of planar chiral ferrocenes via palladium-catalyzed direct coupling with arylboronic acids.
Gao DW; Shi YC; Gu Q; Zhao ZL; You SL
J Am Chem Soc; 2013 Jan; 135(1):86-9. PubMed ID: 23253097
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative activity of hydroxyferrocifen hybrids against triple-negative breast cancer cells.
Cázares-Marinero Jde J; Top S; Vessières A; Jaouen G
Dalton Trans; 2014 Jan; 43(2):817-30. PubMed ID: 24153445
[TBL] [Abstract][Full Text] [Related]
9. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents.
Kumar A; Tripathi VD; Kumar P; Gupta LP; Akanksha ; Trivedi R; Bid H; Nayak VL; Siddiqui JA; Chakravarti B; Saxena R; Dwivedi A; Siddiquee MI; Siddiqui U; Konwar R; Chattopadhyay N
Bioorg Med Chem; 2011 Sep; 19(18):5409-19. PubMed ID: 21871812
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors.
Wambang N; Schifano-Faux N; Aillerie A; Baldeyrou B; Jacquet C; Bal-Mahieu C; Bousquet T; Pellegrini S; Ndifon PT; Meignan S; Goossens JF; Lansiaux A; Pélinski L
Bioorg Med Chem; 2016 Feb; 24(4):651-60. PubMed ID: 26740155
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective synthesis of planar chiral ferrocenes via Pd(0)-catalyzed intramolecular direct C-H bond arylation.
Gao DW; Yin Q; Gu Q; You SL
J Am Chem Soc; 2014 Apr; 136(13):4841-4. PubMed ID: 24625115
[TBL] [Abstract][Full Text] [Related]
13. Ferrocifens labelled with an infrared rhenium tricarbonyl tag: synthesis, antiproliferative activity, quantification and nano IR mapping in cancer cells.
Wang Y; Heinemann F; Top S; Dazzi A; Policar C; Henry L; Lambert F; Jaouen G; Salmain M; Vessieres A
Dalton Trans; 2018 Jul; 47(29):9824-9833. PubMed ID: 29993046
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents.
Kaur G; Mahajan MP; Pandey MK; Singh P; Ramisetti SR; Sharma AK
Eur J Med Chem; 2014 Oct; 86():211-8. PubMed ID: 25164760
[TBL] [Abstract][Full Text] [Related]
15. Formylation of a metathesis-derived
Mazur M; Mrozowicz M; Buchowicz W; Koszytkowska-Stawińska M; Kamiński R; Ochal Z; Wińska P; Bretner M
Dalton Trans; 2020 Aug; 49(33):11504-11511. PubMed ID: 32627790
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
[TBL] [Abstract][Full Text] [Related]
17. Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides.
Wang Y; Pigeon P; Top S; McGlinchey MJ; Jaouen G
Angew Chem Int Ed Engl; 2015 Aug; 54(35):10230-3. PubMed ID: 26179051
[TBL] [Abstract][Full Text] [Related]
18. α-Hydroxylactams as Efficient Entries to Diversely Functionalized Ferrociphenols: Synthesis and Antiproliferative Activity Studies.
Pigeon P; Gaschard M; Othman M; Salmain M; Jaouen G
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889422
[TBL] [Abstract][Full Text] [Related]
19. A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway.
Noori S; Nourbakhsh M; Farzaneh S; Zarghi A
Anticancer Agents Med Chem; 2020; 20(18):2285-2292. PubMed ID: 32767949
[TBL] [Abstract][Full Text] [Related]
20. Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates.
Hillard E; Vessières A; Thouin L; Jaouen G; Amatore C
Angew Chem Int Ed Engl; 2005 Dec; 45(2):285-90. PubMed ID: 16312004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
